Pharmaceuticals

Non-Opioid Pain Treatment Market to Grow at a CAGR of 8.9% from 2025 to 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Non-Opioid Pain Treatment Market Covering 2025–2034?

The non-opioid pain treatment market size has experienced significant expansion in recent years. It is anticipated to grow from $50.63 billion in 2024 to $55.31 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.2%. The contributing factors to its past growth include the increasing prevalence of chronic pain, a rising patient inclination towards safer alternatives, growing public awareness concerning opioid risks, an increasing demand for non-addictive treatments, and escalating healthcare provider initiatives.

The non-opioid pain treatment market is anticipated to experience substantial growth over the next few years. It is projected to expand to $77.67 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is driven by a heightened demand for customized pain management, increasing uptake of non-opioid treatments, a growing elderly demographic, rising investments in the development of non-opioid drugs, and enhanced government support along with favorable reimbursement policies. Significant trends expected in this period involve improvements in drug delivery mechanisms, the adoption of multidisciplinary care strategies, technology-enabled personalized medicine, advancements in non-opioid pharmacological solutions, and progress in patient monitoring instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp

Which Major Market Drivers Are Shaping The Future Of The Non-Opioid Pain Treatment Market?

The non-opioid pain treatment market is anticipated to experience growth driven by the increasing occurrence of sports-related injuries. These injuries refer to physical harm sustained during sports or exercise activities, and their rising incidence is attributed to increased participation in high-intensity sports and recreational pursuits, which elevates athletes’ vulnerability to physical trauma. Non-opioid pain treatment proves beneficial for sports-related injuries by offering effective pain relief and reducing inflammation without the risks linked to opioid use, thus supporting faster recovery, enhanced function, and safer long-term management. For example, in October 2024, Howden Group Holdings Ltd, a UK-based insurance intermediary company, reported that Europe’s top five football leagues recorded 4,123 injuries during the 2023/24 season, marking a 4% increase compared to the previous season. Therefore, the growing number of sports-related injuries is a significant factor propelling the expansion of the non-opioid pain treatment market.

What Are The Major Segment Categories Driving The Non-Opioid Pain Treatment Market Growth?

The non-opioid pain treatment market covered in this report is segmented

1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products

2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes

3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies

5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications

Subsegments:

1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products

2) By Menthol Containing: Topical Creams, Gels, Sprays

3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements

4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A

5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays

6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices

How Are Emerging Market Trends Shaping The Non-Opioid Pain Treatment Industry Landscape?

Leading companies within the non-opioid pain treatment market are prioritizing innovations in drug formulations, particularly non-opioid oral treatments, to deliver effective pain relief and mitigate the dangers associated with opioid use and addiction. Non-opioid oral treatment refers to pain-relieving medications taken by mouth that do not contain opioids and operate through alternative mechanisms, such as reducing inflammation, modulating nerve signals, or acting on specific receptors, thereby managing pain without the addiction potential or respiratory depression often linked to opioids. For instance, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, launched JOURNAVX, a pioneering non-opioid therapy designed to offer effective relief for moderate-to-severe acute pain. This advanced non-opioid treatment specifically modulates pain pathways, presents a favorable safety profile, and achieves a rapid onset of action, resulting in robust pain control, reduced dependency potential, and enhanced patient well-being. It provides targeted pain management, decreases addiction risks, and aids in faster recovery and an improved quality of life for patients experiencing acute pain.

Who Are The Major Companies Operating In The Non-Opioid Pain Treatment Market?

Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report

How Does The Non-Opioid Pain Treatment Market Perform Across Key Geographic Regions?

North America was the largest region in the non-opioid pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Non-Opioid Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27366&type=smp

Browse Through More Reports Similar to the Global Non-Opioid Pain Treatment Market 2025, By The Business Research Company

Polyethylene Pipes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyethylene Pipes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyolefin Pipes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polyolefin-pipes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795